Search

Your search keyword '"Simu, Mihaela"' showing total 303 results

Search Constraints

Start Over You searched for: Author "Simu, Mihaela" Remove constraint Author: "Simu, Mihaela"
303 results on '"Simu, Mihaela"'

Search Results

1. Machine-learning-based prediction of disability progression in multiple sclerosis: An observational, international, multi-center study.

2. Levodopa–Carbidopa–Entacapone Intestinal Gel in Advanced Parkinson Disease: A Multicenter Real-Life Experience

5. An Uncommon Overlap Syndrome Between Ankylosing Spondylitis and Amyotrophic Lateral Sclerosis—Case Report.

7. The Effects of Epigallocatechin-3-Gallate Nutritional Supplementation in the Management of Multiple Sclerosis: A Systematic Review of Clinical Trials.

8. Impact of Ocrelizumab on Disease Progression, Memory Improvement, and Quality of Life in Patients with Relapsing-Remitting Multiple Sclerosis: A Longitudinal MRI and Clinical Criteria Analysis.

14. Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry

15. The risk of secondary progressive multiple sclerosis is geographically determined but modifiable

16. Levodopa Carbidopa Intestinal Gel in Advanced Parkinson’s Disease: DUOGLOBE Final 3-Year Results

18. Emerging Trends in Complications Associated with SARS-CoV-2 Infection.

23. The risk of secondary progressive multiple sclerosis is geographically determined but modifiable

24. Machine-learning-based prediction of disability progression in multiple sclerosis: an observational, international, multi-center study

26. Contributors

27. Conservative versus aggressive antiplatelet strategy for emergent carotid stenting during stroke thrombectomy.

30. Risk for Major Bleeding in Patients Receiving Ticagrelor Compared With Aspirin After Transient Ischemic Attack or Acute Ischemic Stroke in the SOCRATES Study (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes)

31. Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson’s Disease: Observations and Dilemmas after 10 Years of Real-Life Experience

32. Real-world Effect of Age on Long-term Effectiveness and Safety of Levodopa-Carbidopa Intestinal Gel: A Post Hoc Analysis From the Prospective, Multinational, Observational DUOGLOBE Study (P9-11.007)

33. Long-term Motor and Non-Motor Symptom Benefits in Patients With Advanced Parkinson’s Disease Treated With Levodopa-Carbidopa Intestinal Gel: Final Analysis of the 36-Month DUOGLOBE Real-world Multinational Observational Study (P1-1.Virtual)

34. Long-term Motor and Non-Motor Symptom Benefits in Patients With Advanced Parkinson’s Disease Treated With Levodopa-Carbidopa Intestinal Gel by Baseline Hoehn & Yahr Stage: Analysis of the DUOGLOBE Study (P1-1.Virtual)

35. Outcomes Impacting Quality of Life in Advanced Parkinson’s Disease Patients Treated with Levodopa-Carbidopa Intestinal Gel

36. Conservative versus aggressive antiplatelet strategy for emergent carotid stenting during stroke thrombectomy

41. Sustained improvements in motor and non-motor symptoms in advanced Parkinson's disease patients treated with carbidopa levodopa enteral suspension in a ‘real-world’ study

44. DUOGLOBE : One‐Year Outcomes in a Real‐World Study of Levodopa Carbidopa Intestinal Gel for Parkinson's Disease

45. Affective theory of mind in Parkinson’s disease: the effect of cognitive performance

46. Plasma hsa‐mir‐19b is a potential LevoDopa therapy marker

47. Management Challenges of Severe, Complex Dyskinesia. Data from a Large Cohort of Patients Treated with Levodopa-Carbidopa Intestinal Gel for Advanced Parkinson’s Disease

49. Traitement antiagrégant plaquettaire après stenting carotidien en urgence lors des thrombectomies cérébrales pour occlusions en tandem–impact sur la perméabilité des stents au-delà des premières 24 heures

50. The Relationship Between Type D Personality and the Complexity of Coronary Artery Disease

Catalog

Books, media, physical & digital resources